-
Product Insights
Epilepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in the brain which causes seizures. This leads to brief disruptions of the senses and short periods of unconsciousness or convulsions. Symptoms of epilepsy are repeated seizures, weakness, anxiety, loss of consciousness, and contraction or jerking of body muscles. The Epilepsy Drugs in Development market research report provides an overview of the Epilepsy pipeline landscape. The report provides comprehensive information on the...
-
Sector Analysis
PharmaPoint: Prostate Cancer – Global Drug Forecast and Market Analysis to 2026
The prostate cancer market is expected to experience a moderate growth between 2016 and 2026. The main drivers of growth will be the expected label expansion of second-generation hormonal agents into hormone-sensitive disease and non-metastatic castration resistant prostate cancer (nmCRPC), and the launch and uptake of nine new premium-priced therapies. Until now, the hormone sensitive setting has been dominated by the use of cheap first-generation hormonal agents, with the use of premium-priced second-generation hormonal agents (Xtandi and Zytiga) limited to...
-
Government & Regulation
US Alaska Upstream Fiscal and Regulatory Report – Budget Problems May Force Fiscal Regime Changes
The reduction in tax credits, the large long-term state budget liabilities, and the inability to repay the investment credits, may force Alaska to modify its petroleum fiscal framework just a few years after the modification introduced by MAPA in 2013. The reduction in tax credits coupled with the difficulties in legally establishing the Alaska Tax Credit Certificate Bond Corporation and its bond repurchase program may dampen investment sentiment across Alaska despite the reduction at the federal level of corporate income...
-
Government & Regulation
Alaska Upstream Fiscal and Regulatory Report – Tax Credit Reductions Increase Fiscal Burden, Further Reductions Possible
“Alaska Upstream Fiscal and Regulatory Report - Tax Credit Reductions Increase Fiscal Burden, Further Reductions Possible”, presents the essential information relating to the terms which govern investment into Alaska’s upstream oil and gas sector. The report sets out in detail the contractual framework under which firms must operate in the industry, clearly defining factors affecting profitability and quantifying the state’s take from hydrocarbon production. Considering political, economic and industry specific variables, the report also analyses future trends for Alaska’s upstream...
-
Sector Analysis
Australian Consumer Credit: Forecasts and Future Opportunities
GlobalData’s “Australian Consumer Credit: Forecasts and Future Opportunities” report analyzes the Australian consumer credit market, with coverage of both supply and demand factors as well as sectoral analysis. Consumer reservations about debt levels and repayment will relax as the economy continues to grow and unemployment falls. However, consumers will be cautious about taking on new debt, with consumer credit gross advances growing by a modest CAGR of 2.7% between 2017–20. Outstanding balances and gross advances have yet to reach pre-crisis...